Epstein Secrets

d, and America's place in it." As a candidate, Donald Trump that he would push for a great healthcare bill that covers everyone and would not touch Medicaid. To get a win at any cost, he has pushed Congressional legislators to pass the current GOP healthcare bill which does neither. But more importantly,

st 22% are similarly optimistic about his successor, whom they described as "arrogant" (75%), "intolerant" (65%) and "dangerous" (62%). Citizens in Western Europe put no more stock in Mr Trump — who took office just five months ago — than they did in George W. Bush, the architect of the highly unpopular war in

modest decline in the growth rate in recent years, healthcare continues to account for a very high portion of U.S. GDP. The Centers for Medicare and Medicaid (CMS) estimates healthcare spending in the United States will reach $5 trillion in 2022 and represent about 20 percent of GDP. Long term CMS expect

tries, including emerging countries that have legal and regulatory environments that are significantly different from those of the United States or Western Europe. Specifically, investments in such companies may be subject to (i) economic, market, political and local risks related to the governmental systems i

cal Properties Trust Elevated government reimbursement risk While an updated payor mix has not been provided since August 2014, Medicare (38%) and Medicaid (13%) accounted for roughly half of US net revenue at that point. This is a function of MPW's focus on hospitals, which have a higher government pa

revenue SWAM DIttICA• alsep••• oft& Diversifying internationally MPW's portfolio is primarily located in the US, with an increasing exposure to Western Europe. MPW has a target portfolio mix of 70% US to 30% Europe, though the mix may shift outside these targets periodically. By investment, the mix is cur

year before. The change w=s driven mainly by increased coverage through the AFFORDABLE CARE ACT's HEALTH INSURANCE EXCHANGES a=d by the expansion of Medicaid access in more than half the country, the Gallup-Healthways Well-Being Index shows, based on more than 43,000 intervi=ws conducted between Oct. 1 an

in the march in Paris last week and other sympathetic events around the world. Concurrent=y it is evident that a number of these heinous events in Western Europe, North Amer=ca, Middle East and elsewhere are the acts of home grown terrorist who after go=ng abroad where they were proselytized and trained radi

oval process for generic biologics and granting exclusive marketing rights to original manufacturers for 12 years, (iv) increased drug rebates to the Medicaid program, and (v) disclosure requirements for financial relationships between various healthcare entities. Within the U.S., the pharmaceutical indust

s & Infrastructure. Investments will be predominantly in the U.S., but could include a small number of investments in other parts of the world (e.g., Western Europe or Canada). The focus within each sector will be the following: Biopharmaceuticals: As in NLV-I and NLV-II, biopharmaceutical investments will be th